Document is current
Any future updates will be listed below
-
Authors
Gillett, George https://orcid.org/0000-0002-0270-9369
Joyce, Dan W. https://orcid.org/0000-0002-9433-5340
Ginestet, Cedric E.
MacCabe, James H. https://orcid.org/0000-0002-6754-1018
Meyer, Nicholas
- License Information
-
More Information
Article History
Received: 24 January 2025
Accepted: 4 June 2025
First Online: 3 July 2025
Competing interests
: Professor MacCabe has received investigator-initiated research funding from H Lundbeck. He has received research funding for clinical trials from H Lundbeck and Karuna Therapeutics, and has participated in advisory boards for H Lundbeck, LB Pharma, Newron Pharmaceuticals and Teva UK Ltd. Dr. Nicholas Meyer has received speaker fees from Idorsia Pharmaceuticals. Dr George Gillett has served as a consultant within the last 3 years for Boehringer Ingelheim. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The remaining authors have nothing to disclose.
: Ethical approval was obtained from the Dulwich Research and Ethics Committee, London, UK. Written informed consent was obtained from all participants.
